Explore ViiV Healthcare
Report adverse event
If you are a patient and have experienced an unexpected event when taking one of our medications please speak to your healthcare professional as soon as possible. To lodge a report contact:
Phone: 1800 499 226
Vocabria (cabotegravir) is listed on the Australian Register of Therapeutic Goods (ARTG).
VOCABRIA is used to treat HIV infection in adults. VOCABRIA tablets contain cabotegravir, which belongs to a group of antiretroviral medicines called integrase inhibitors (INIs). VOCABRIA tablets are always given in combination with another antiretroviral medicine, rilpivirine, to treat HIV infection.
VOCABRIA tablets do not cure HIV infection; in combination with rilpivirine, they keep the amount of virus in your body at a low level.
Date of Preparation: February 2021. PM-AU-CBR-WCNT-210003